thalidomide has been researched along with Peritoneal Diseases in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Peritoneal Diseases: Pathological processes involving the PERITONEUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to assess the efficacy of thalidomide for treatment of experimental endometriosis." | 7.80 | Thalidomide affects experimental endometriosis: a randomized controlled study in the rat. ( Alborzi, S; Azimirad, A; Azimirad, M; Kumar, PV; Tavana, Z; Zarei, A; Zolghadri, J, 2014) |
| "Multiple angiomatosis is a very rare disease formed by histologically benign angiomas spreading beyond single organ or tissue." | 5.35 | [Treatment of multiple angiomatosis involving the skeleton and the abdominal and thoracic cavities with interferon alpha, thalidomide and zoledronate]. ( Adam, Z; Krejcí, M; Krikavová, L; Mechl, M; Moulis, M; Navrátil, M; Neumann, C; Pour, L; Vanícek, J; Veselý, K; Vorlícek, J, 2008) |
| "This study aimed to assess the efficacy of thalidomide for treatment of experimental endometriosis." | 3.80 | Thalidomide affects experimental endometriosis: a randomized controlled study in the rat. ( Alborzi, S; Azimirad, A; Azimirad, M; Kumar, PV; Tavana, Z; Zarei, A; Zolghadri, J, 2014) |
| "Multiple angiomatosis is a very rare disease formed by histologically benign angiomas spreading beyond single organ or tissue." | 1.35 | [Treatment of multiple angiomatosis involving the skeleton and the abdominal and thoracic cavities with interferon alpha, thalidomide and zoledronate]. ( Adam, Z; Krejcí, M; Krikavová, L; Mechl, M; Moulis, M; Navrátil, M; Neumann, C; Pour, L; Vanícek, J; Veselý, K; Vorlícek, J, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azimirad, A | 1 |
| Alborzi, S | 1 |
| Kumar, PV | 1 |
| Zolghadri, J | 1 |
| Zarei, A | 1 |
| Tavana, Z | 1 |
| Azimirad, M | 1 |
| Hirata, H | 1 |
| Fumoto, S | 1 |
| Miyamoto, H | 1 |
| Nakashima, M | 1 |
| Nakayama, M | 1 |
| Nishida, K | 1 |
| Adam, Z | 1 |
| Krikavová, L | 1 |
| Krejcí, M | 1 |
| Mechl, M | 1 |
| Pour, L | 1 |
| Moulis, M | 1 |
| Vanícek, J | 1 |
| Neumann, C | 1 |
| Navrátil, M | 1 |
| Veselý, K | 1 |
| Vorlícek, J | 1 |
3 other studies available for thalidomide and Peritoneal Diseases
| Article | Year |
|---|---|
Thalidomide affects experimental endometriosis: a randomized controlled study in the rat.
Topics: Angiogenesis Inhibitors; Animals; Disease Models, Animal; Endometriosis; Female; Immunosuppressive A | 2014 |
Evaluation for Peritoneal Injury at an Early Stage Using Dual Macromolecular Markers.
Topics: Animals; Chlorhexidine; Dextrans; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Injections, Intrap | 2016 |
[Treatment of multiple angiomatosis involving the skeleton and the abdominal and thoracic cavities with interferon alpha, thalidomide and zoledronate].
Topics: Adult; Angiogenesis Inhibitors; Angiomatosis; Diagnosis, Differential; Diphosphonates; Drug Therapy, | 2008 |